AlphaStar Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,815
Closed -$507K 209
2025
Q2
$507K Buy
+1,815
New +$514K 0.04% 223
2024
Q4
Sell
-2,278
Closed -$734K 214
2024
Q3
$734K Sell
2,278
-672
-23% -$220K 0.06% 190
2024
Q2
$922K Sell
2,950
-318
-10% -$93.4K 0.09% 146
2024
Q1
$929K Sell
3,268
-710
-18% -$208K 0.1% 124
2023
Q4
$1.15M Sell
3,978
-649
-14% -$177K 0.1% 101
2023
Q3
$1.24M Sell
4,627
-615
-12% -$153K 0.16% 82
2023
Q2
$1.16M Sell
5,242
-2,967
-36% -$688K 0.13% 104
2023
Q1
$1.98M Buy
8,209
+828
+11% +$203K 0.17% 90
2022
Q4
$1.94M Buy
7,381
+334
+5% +$89.5K 0.2% 95
2022
Q3
$1.59M Buy
7,047
+1,742
+33% +$422K 0.17% 101
2022
Q2
$1.29M Buy
5,305
+735
+16% +$180K 0.12% 132
2022
Q1
$1.1M Buy
4,570
+263
+6% +$60.4K 0.09% 158
2021
Q4
$1.01M Sell
4,307
-1,381
-24% -$291K 0.08% 177
2021
Q3
$1.2M Buy
5,688
+2,535
+80% +$583K 0.08% 184
2021
Q2
$768K Buy
3,153
+241
+8% +$59.3K 0.1% 154
2021
Q1
$725K Buy
2,912
+64
+2% +$15.3K 0.11% 129
2020
Q4
$699K Sell
2,848
-136
-5% -$31.4K 0.12% 117
2020
Q3
$688K Buy
2,984
+216
+8% +$53.5K 0.14% 101
2020
Q2
$701K Buy
2,768
+370
+15% +$84.4K 0.15% 97
2020
Q1
$553K Sell
2,398
-2,494
-51% -$545K 0.13% 112
2019
Q4
$1.18M Buy
4,892
+306
+7% +$67.5K 0.26% 70
2019
Q3
$887K Sell
4,586
-427
-9% -$82K 0.21% 81
2019
Q2
$924K Buy
5,013
+1,042
+26% +$187K 0.23% 73
2019
Q1
$755K Sell
3,971
-284
-7% -$54.2K 0.21% 83
2018
Q4
$828K Sell
4,255
-344
-7% -$67.1K 0.26% 80
2018
Q3
$953K Sell
4,599
-542
-11% -$107K 0.28% 77
2018
Q2
$949K Buy
5,141
+2,500
+95% +$442K 0.3% 78
2018
Q1
$450K Buy
2,641
+209
+9% +$38.4K 0.17% 105
2017
Q4
$423K Buy
+2,432
New +$430K 0.11% 117

Other funds holding AMGN

AlphaStar Capital Management's AMGN Position: Q3 2025 in Review

AlphaStar Capital Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 1,815 shares — an estimated $507K sold.

AlphaStar Capital Management first reported a position in AMGN in Q4 2017 and held it in 29 quarters. The position peaked at $1.98M in Q1 2023. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • AlphaStar Capital Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • AlphaStar Capital Management sold 1,815 Amgen shares in Q3 2025, an estimated $507K.
  • AlphaStar Capital Management first reported a position in Amgen in Q4 2017 and held it in 29 quarters.
  • AlphaStar Capital Management's Amgen position peaked at $1.98M in Q1 2023.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on AlphaStar Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.